2024
Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink
Denoble A, Vazquez-Benitez G, Sheth S, Ackerman-Banks C, DeSilva M, Zhu J, Daley M, Getahun D, Klein N, Vesco K, Irving S, Nelson J, Williams J, Hambidge S, Donahue J, Weintraub E, Kharbanda E, Lipkind H. Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink. Obstetrics And Gynecology 2024, 144: 215-222. PMID: 38843526, PMCID: PMC11250101, DOI: 10.1097/aog.0000000000005632.Peer-Reviewed Original ResearchVaccine Safety DatalinkAntepartum stillbirthVaccine Safety Datalink sitesLive birthsCOVID-19 vaccineVaccine dosePregnancy start dateRisk of severe morbidityRisk of stillbirthConditional logistic regressionCase-control studyVaccine manufacturersSingleton pregnanciesGestational ageFetal deathPostpartum visitMaternal ageIndex dateSevere morbidityDiagnostic codesPregnancyStillbirthPregnant peopleCOVID-19Logistic regression
2019
Management of Intraamniotic Infection After Spontaneous Vaginal Delivery: Is Nothing Really Enough? [24C]
Daifotis H, Smith M, Denoble A, Dotters-Katz S. Management of Intraamniotic Infection After Spontaneous Vaginal Delivery: Is Nothing Really Enough? [24C]. Obstetrics And Gynecology 2019, 133: 37s-37s. DOI: 10.1097/01.aog.0000559445.77903.c7.Peer-Reviewed Original ResearchPostpartum infectious complicationsSpontaneous vaginal deliveryIntraamniotic infectionUrinary tract infectionInfectious complicationsAntibiotic therapyVaginal deliveryIntrapartum antibiotic therapyHigh-risk criteriaHigh-risk womenSingle academic centerWeeks of deliveryCase-control studyAntepartum complicationsTract infectionsWeeks' gestationRisk factorsAntimicrobial therapyCurrent guidelinesAcademic centersIRB approvalControl studyDemographic dataComplicationsInfection